41% of the people admitted for chronic obstructive pulmonary disease (COPD) are readmitted during follow-up and 15% die in the three months after discharge. These are the first data from the ADEG-COPD multicenter study of the Sociedad Española de Medicina Interna (SEMI), which attributes largely these figures to the high burden of comorbidities, responsible for the increase in mortality and readmissions in these patients.
The research, promoted by the Working Group on COPD and Respiratory Diseases of the SEMI and funded with a competitive grant from GSK international/Europe, will be presented in detail at the 47th National Congress of the Sociedad Española de Medicina Interna (SEMI), to be held in Murcia from November 25 to 27.
ADEG-COPD is a multicenter, observational, prospective and longitudinal study in which 28 hospitals from 10 autonomous communities have collaborated. The study included 350 patients consecutively admitted for an acute exacerbation of COPD, with follow-up at 3 and 12 months after hospital discharge to analyze their clinical course, the recurrence of acute episodes, and the medium- and long-term prognosis.
The main purpose has been to define with precision the clinical profile and the burden of concomitant diseases of patients hospitalized for an exacerbation of COPD, as well as to assess to what extent the recommendations of the reference clinical guidelines (GOLD and GesEPOC) are met in real practice in Spanish hospitalization services.
The data indicate that the typical admitted COPD patient is a man of about 75 years on average, an ex-smoker and with severe obstruction of airflow (average FEV1 of 50%). However, the key element that defines this group is its marked systemic multi-morbidity.
Among the most frequent comorbidities are arterial hypertension, present in 69.4% of cases; disorders of lipids or dyslipidemia, in 53.8%; diabetes mellitus, in 35.7%; atrial fibrillation, in 31.3%; heart failure, in 28.7%; and anxiety or depression disorders, in 21%.
During the first year after discharge, 33.3% of these patients visited the Emergency Department service. In addition, longitudinal follow-up highlights a high degree of care-related fragility: 15% had died at three months and 41% had returned to be admitted to the ward within the first year after discharge.
"The ADEG-EPOC study clearly shows that the accumulation of comorbidities constitutes the most determining prognostic factor in the unfavorable evolution of the patient. A direct and statistically significant association has been observed between a higher comorbidity burden and an increase in mortality one year after hospital discharge," explains Dr. Díaz Peromingo, the presenter of the study at the 47th SEMI Congress.
"The study shows that only around 40% of patients follow the recommendations of clinical guidelines appropriately during the acute episode, which evidences the difficulties in applying these guidelines in patients with multiple diseases and high clinical complexity," explains Dr. Francisco Javier Medrano, coordinator of the EPOC and Respiratory Diseases Working Group of SEMI and driving force behind the ADEG-EPOC study.
"Internists have a global view of the patient, their disease, and comorbidities, and we are trained and accustomed to provide more coordinated care adapted to the clinical reality of each patient," he adds.
Three priority lines of action to improve prognosis
With the aim of improving clinical outcomes and reducing complications, SEMI proposes three priority intervention areas. The first is to optimize the use of oral corticosteroids, precisely adjusting the dose and duration of systemic corticosteroids to reduce metabolic decompensations and secondary hyperglycemias during the admission.
Secondly, it is proposed to standardize thromboembolic prophylaxis according to the individual risk of the hospitalized patient, using the PRETEMED scale as a reference. Thirdly, it is argued to integrate digital tools to support clinical decision-making directly into the hospital’s electronic medical record, so that they facilitate the application of the guidelines in complex patients.
Based on the results of ADEG-EPOC, SEMI emphasizes that future research lines should be oriented toward personalizing treatment and validating prognostic scales with predictive capacity, such as CODEX, BODEX, or the adjusted Charlson index.